An update of genetic basis of PCOS pathogenesis
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder that affects 5-20% of reproductive age women. PCOS clinical symptoms include hirsutism, menstrual dysfunction, infertility, obesity and metabolic syndrome. There is a wide heterogeneity in clinical manifestations and metabolic complications. The pathogenesis of PCOS is not fully elucidated, but four aspects seem to contribute to the syndrome to different degrees: increased ovarian and/or adrenal androgen secretion, partial folliculogenesis arrest, insulin resistance and neuroendocrine axis dysfunction. A definitive etiology remains to be elucidated, but PCOS has a strong heritable component indicated by familial clustering and twin studies. Genome Wide Association Studies (GWAS) have identified several new risk loci and candidate genes for PCOS. Despite these findings, the association studies have explained less than 10% of heritability. Therefore, we could speculate that different phenotypes and subphenotypes are caused by rare private genetic variants. Modern genetic studies, such as whole exome and genome sequencing, will help to clarify the contribution of these rare genetic variants on different PCOS phenotypes. Arch Endocrinol Metab. 2018;62(3):352-61.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A large number of genetic and genome-wide association studies (GWAS) have identified common gene loci associated with PCOS phenotypes in different ethnic populations [29,30,31].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This adaptive protective mechanism can be pathway-specific during periods of growth, such as pregnancy, lactation and adolescence, so that only the metabolic signaling (PI-3K) is inhibited and not the mitogenic pathway (MAPK), which may even be up-regulated [30,65,160].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · cited 1×
“In 2006, the Androgen Excess Society proposed a modification, in which hyperandrogenism would be an essential condition for diagnosis, reducing the number of phenotypic possibilities (5).”
BackgroundAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Defects in metabolic actions of insulin occur in muscle and adipose tissues, but mitogenic and steroidogenic actions of insulin in ovaries are preserved (28).”
BackgroundLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
The Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
The Syndromes of Insulin Resistance and Acanthosis Nigricans: Insulin-Receptor Disorders in Man
Kahn, C. R., Flier, J. S., Bar, R. S., Archer, J. A., Gorden, P., Martin, M. M., & Roth, J. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941401 · Cited by 1,106
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
BURGHEN, G. A., GIVENS, J. R., & KITABCHI, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Shi, Y., Zhao, H., Shi, Y., Cao, Y., Yang, D., Li, Z., Zhang, B., Liang, X., Li, T., Chen, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2384 · Cited by 678 · cited 2×
“Han Chinese: 2011 (41), 2012 (42) European 1 2015 (47) European 2 2015 (48)”
BackgroundHeritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647
Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
Pellatt, L., Hanna, L., Brincat, M., Galea, R., Brain, H., Whitehead, S., & Mason, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1582 · Cited by 521
Urbanek, M., Legro, R. S., Driscoll, D. A., Azziz, R., Ehrmann, D. A., Norman, R. J., Strauss, J. F., Spielman, R. S., & Dunaif, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8573 · Cited by 486
Hayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8502 · Cited by 478 · cited 2×
“These data were validated in Caucasians, confirming the presence of 12 out of the 17 variants with the same risk effect, indicating a similar genetic risk profile in different populations (43-48).”
MethodDay, F. R., Hinds, D. A., Tung, J. Y., Stolk, L., Styrkarsdottir, U., Saxena, R., Bjonnes, A., Broer, L., Dunger, D. B., Halldorsson, B. V., et al. (2015) · Nature Communications · doi:10.1038/ncomms9464 · Cited by 459 · cited 2×
“These data were validated in Caucasians, confirming the presence of 12 out of the 17 variants with the same risk effect, indicating a similar genetic risk profile in different populations (43-48).”
MethodPrevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS
Kahsar-Miller, M. D., Nixon, C., Boots, L. R., Go, R. C., & Azziz, R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01662-9 · Cited by 406 · cited 1×
“studied first-degree relatives of 93 PCOS patients and found that 35% of non-menopausal mothers and 40% of sisters were also affected (36).”
BackgroundEagleson, C. A., Gingrich, M. B., Pastor, C. L., Arora, T. K., Burt, C. M., Evans, W. S., & Marshall, J. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6992 · Cited by 345
Mutations in the Insulin Receptor Gene
TAYLOR, S. I., CAMA, A., ACCILI, D., BARBETTI, F., QUON, M. J., SIERRA, M. D. L. L., SUZUKI, Y., ROLLER, E., LEVY-TOLEDANO, R., WERTHEIMER, E., et al. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-566 · Cited by 311
Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285 · cited 1×
“In11β-HSD type I deficiency, cortisone is not convert into cortisol, with a consequent elevation of ACTH, which stimulates androgen production, leading to the PCOS phenotype (14).”
BackgroundEagleson, C. A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4047 · Cited by 284
Robinson, S., Kiddy, D., Gelding, S. V., Willis, D., Niththyananthan, R., Bush, A., Johnston, D. G., & Franks, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02376.x · Cited by 283
Musso, C., Cochran, E., Moran, S. A., Skarulis, M. C., Oral, E. A., Taylor, S., & Gorden, P. (2004) · Medicine · doi:10.1097/01.md.0000133625.73570.54 · Cited by 264 · cited 1×
“The molecular mechanism of insulin resistance in these diseases was explained by a reduction in the binding of insulin to its receptor and by a defect in insulin receptor autophosphorylation (22,23).”
BackgroundPastor, C. L., Griffin-Korf, M. L., Aloi, J. A., Evans, W. S., & Marshall, J. C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4604 · Cited by 263 · cited 1×
“It is known that PCOS patients present a GnRH-generating pulse resistance to negative feedback by progesterone, which results in a higher LH pulses frequency and/or amplitude (33).”
BackgroundDivergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262 · cited 2×
“2018;62/3 of each phenotype is about 70% for classic, 15% for ovulatory and 15% for normoandrogenic phenotypes (7).”
BackgroundOverexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype
McAllister, J. M., Modi, B., Miller, B. A., Biegler, J., Bruggeman, R., Legro, R. S., & Strauss, J. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400574111 · Cited by 250 · cited 2×
“V2), which encodes a truncated 559-aa protein that contains the DENN domain and a clathrin-binding domain; however, the protein lacks the proline-rich domain and includes a C-terminal 33-aa sequence that is not found in the larger connecdenn variant 1 (49).”
BackgroundMissense mutations in the BMP15 gene are associated with ovarian failure
Dixit, H., Rao, L. K., Padmalatha, V. V., Kanakavalli, M., Deenadayal, M., Gupta, N., Chakrabarty, B., & Singh, L. (2006) · Human Genetics · doi:10.1007/s00439-006-0150-0 · Cited by 225
Functional genomics of PCOS: from GWAS to molecular mechanisms
McAllister, J. M., Legro, R. S., Modi, B. P., & Strauss, J. F. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.12.004 · Cited by 219
An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female
Toledo, S. P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3850 · Cited by 213
Hereditary factors in the Stein-Leventhal syndrome
Cooper, H. E., Spellacy, W. N., Prem, K. A., & Cohen, W. D. (1968) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)33704-2 · Cited by 211 · cited 1×
“Since 1968, studies have suggested an important genetic role contributing to the etiology of PCOS (35).”
BackgroundEffective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass
Eid, G. M., Cottam, D. R., Velcu, L. M., Mattar, S. G., Korytkowski, M. T., Gosman, G., Hindi, P., & Schauer, P. R. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2005.02.008 · Cited by 209
Goodarzi, M. O., Jones, M. R., Li, X., Chua, A. K., Garcia, O. A., Chen, Y.-D. I., Krauss, R. M., Rotter, J. I., Ankener, W., Legro, R. S., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100427 · Cited by 199
Garg, A., Peshock, R. M., & Fleckenstein, J. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5383 · Cited by 197
Goodarzi, M. O., Carmina, E., & Azziz, R. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.06.003 · Cited by 188
Wu, S., Divall, S., Nwaopara, A., Radovick, S., Wondisford, F., Ko, C., & Wolfe, A. (2014) · Diabetes · doi:10.2337/db13-1514 · Cited by 176
Fallat, M. E., Siow, Y., Marra, M., Cook, C., & Carrillo, A. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81417-3 · Cited by 174
Variants in DENND1A Are Associated with Polycystic Ovary Syndrome in Women of European Ancestry
Welt, C. K., Styrkarsdottir, U., Ehrmann, D. A., Thorleifsson, G., Arason, G., Gudmundsson, J. A., Ober, C., Rosenfield, R. L., Saxena, R., Thorsteinsdottir, U., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3478 · Cited by 169
The role of AMH in the pathophysiology of polycystic ovarian syndrome
Garg, D., & Tal, R. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.04.007 · Cited by 150
Garg, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.170 · Cited by 149
Mutharasan, P., Galdones, E., Peñalver Bernabé, B., Garcia, O. A., Jafari, N., Shea, L. D., Woodruff, T. K., Legro, R. S., Dunaif, A., & Urbanek, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2471 · Cited by 134
Latronico, A. C., Chai, Y., Arnhold, I. J. P., Liu, X., Mendonca, B. B., & Segaloff, D. L. (1998) · Molecular Endocrinology · doi:10.1210/me.12.3.442 · Cited by 129
Cross-Ethnic Meta-Analysis of Genetic Variants for Polycystic Ovary Syndrome
Louwers, Y. V., Stolk, L., Uitterlinden, A. G., & Laven, J. S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2495 · Cited by 128
Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome
Talbot, J. A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1979 · Cited by 123
Moller, D. E., Yokota, A., White, M. F., Pazianos, A. G., & Flier, J. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77212-8 · Cited by 119
Genetic determinants of polycystic ovary syndrome: Progress and future directions
Jones, M. R., & Goodarzi, M. O. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.04.040 · Cited by 117
Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome
Gorsic, L. K., Kosova, G., Werstein, B., Sisk, R., Legro, R. S., Hayes, M. G., Teixeira, J. M., Dunaif, A., & Urbanek, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00612 · Cited by 104
Genetics of polycystic ovary syndrome
Mykhalchenko, K., Lizneva, D., Trofimova, T., Walker, W., Suturina, L., Diamond, M. P., & Azziz, R. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1340833 · Cited by 98
Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome
Mikaeili, S., Rashidi, B. H., Safa, M., Najafi, A., Sobhani, A., Asadi, E., & Abbasi, M. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4068-z · Cited by 81
Wei, L., Huang, R., Li, L., Fang, C., Li, Y., & Liang, X. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-014-0319-8 · Cited by 76
Overbeek, A., Kuijper, E. A. M., Hendriks, M. L., Blankenstein, M. A., Ketel, I. J. G., Twisk, J. W. R., Hompes, P. G. A., Homburg, R., & Lambalk, C. B. (2009) · Human Reproduction · doi:10.1093/humrep/dep114 · Cited by 76
Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?
Gunning, M. N., & Fauser, B. C. J. M. (2017) · Climacteric · doi:10.1080/13697137.2017.1316256 · Cited by 71
Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome
Li, T., Zhao, H., Zhao, X., Zhang, B., Cui, L., Shi, Y., Li, G., Wang, P., & Chen, Z.-J. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100727 · Cited by 69
The post-translational regulation of 17,20 lyase activity
Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 56
Latronico, A. C., Lins, T. S. S., Brito, V. N., Arnhold, I. J. P., & Mendonca, B. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01135.x · Cited by 42
Insights from exome sequencing for endocrine disorders
de Bruin, C., & Dauber, A. N. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.72 · Cited by 38
Louwers, Y. V., de Jong, F. H., van Herwaarden, N. A. A., Stolk, L., Fauser, B. C. J. M., Uitterlinden, A. G., & Laven, J. S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1976 · Cited by 26
Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome
Çelik, E., Türkçüoğlu, İ., Ata, B., Karaer, A., Kirici, P., Eraslan, S., Taşkapan, Ç., & Berker, B. (2016) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2016.16133 · Cited by 18
Research works printed but not linked: 1
- 3. JK Z. Diagnostic criteria of polycystic ovary syndrome; towards a rational approach. In: Dunaif A, ditor. Polycystic Ovary Syndrome ed. Boston, MA: Blackwell Scientific; 1992.
Cited by
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557
Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives
Khan, M. J., Ullah, A., & Basit, S. (2019) · The Application of Clinical Genetics · doi:10.2147/tacg.s200341 · Cited by 354
Hiam, D., Moreno-Asso, A., Teede, H. J., Laven, J. S. E., Stepto, N. K., Moran, L. J., & Gibson-Helm, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101606 · Cited by 126
Hyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131
“The risk genes regulate a variety of reproductive and metabolic function, including gonadotropin secretion (FSHB), gonadotropin action and ovarian function (LHCGR, FSHR, DENND1A, RAB5/SUOX, HMGA2, C9orf3, YAP1, TOX3, RAD50, FBN3, and AMH) and metabolic function (THADA, GATA/NEIL2, ERBB4, SUMOP11, INSR, and KRR1) [21,2…”
Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
Parker, J., O’Brien, C., Hawrelak, J., & Gersh, F. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031336 · Cited by 114
“This adaptive protective mechanism can be pathway-specific during periods of growth, such as pregnancy, lactation and adolescence, so that only the metabolic signaling (PI-3K) is inhibited and not the mitogenic pathway (MAPK), which may even be up-regulated [30,65,160].”
Background
Metadata
- Authors
- Crespo, R. P., Bachega, T. A. S. S., Mendonça, B. B., & Gomes, L. G.
- Affiliations
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- ORCID
- Gomes, Larissa G.
- Venue
- Archives of Endocrinology and Metabolism
- Published
- 2018-06
- Volume
- 62
- Issue
- 3
- Pages
- 352-361
- ISSN
- 2359-3997 (ISSN-L)
- 2359-4292
- PMC
- PMC10118782
- OpenAlex
- W2810280311
- Cited by
- 138
- References
- 65
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 27 · 2023: 19 · 2022: 22 · 2021: 18 · 2020: 24 · 2019: 13
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Archives of Endocrinology and Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, PCOS pathogenesis, genetic basis, heritability, genome-wide association study, candidate genes, rare variants, hyperandrogenism, insulin resistance, folliculogenesis, neuroendocrine dysfunction, PCOS phenotypes, twin studies, familial aggregation
- MeSH terms
- Female, Humans, Phenotype, Polycystic Ovary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.